The Ca2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms

Gabriel E. Bertolesi; Chanjuan Shi; Lindsy Elbaum; Christine Jollimore; Gabriela Rozenberg; Steven Barnes; Melanie E.M. Kelly

doi:10.1124/mol.62.2.210

The Ca²⁺ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms

Gabriel E. Bertolesi, Chanjuan Shi, Lindsy Elbaum, Christine Jollimore, Gabriela Rozenberg, Steven Barnes, Melanie E.M. Kelly

Decision Sciences

科研成果: 期刊稿件 › 文章 › 同行评审

115 引用（Scopus）

源语言	英语
页（从-至）	210-219
页数	10
期刊	Molecular Pharmacology
卷	62
期	2
DOI	https://doi.org/10.1124/mol.62.2.210
出版状态	已出版 - 2002

!!!ASJC Scopus Subject Areas

分子药学
药理学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1124/mol.62.2.210

其它文件与链接

引用此

@article{acc8eaa828cd4e448271596224502cc8,

title = "The Ca2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms",

author = "Bertolesi, {Gabriel E.} and Chanjuan Shi and Lindsy Elbaum and Christine Jollimore and Gabriela Rozenberg and Steven Barnes and Kelly, {Melanie E.M.}",

year = "2002",

doi = "10.1124/mol.62.2.210",

language = "English",

volume = "62",

pages = "210--219",

journal = "Molecular Pharmacology",

issn = "0026-895X",

publisher = "American Society for Pharmacology and Experimental Therapeutics",

number = "2",

}

TY - JOUR

T1 - The Ca2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms

AU - Bertolesi, Gabriel E.

AU - Shi, Chanjuan

AU - Elbaum, Lindsy

AU - Jollimore, Christine

AU - Rozenberg, Gabriela

AU - Barnes, Steven

AU - Kelly, Melanie E.M.

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=0036073980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036073980&partnerID=8YFLogxK

U2 - 10.1124/mol.62.2.210

DO - 10.1124/mol.62.2.210

M3 - Article

C2 - 12130671

AN - SCOPUS:0036073980

SN - 0026-895X

VL - 62

SP - 210

EP - 219

JO - Molecular Pharmacology

JF - Molecular Pharmacology

IS - 2

ER -